Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
3SBIO Plans 6.5% Discounted Shr Placement to Raise ~$3.09B Net
Recommend 4 Positive 2 Negative 8 |
||||
|
||||
|
3SBIO (01530.HK) announced plans to place over 105 million shares, representing approximately 4.14% of the enlarged issued share capital, at a placement price of HKD29.62 per share, which is a 6.5% discount to the previous trading day's closing price of HKD31.68. The net proceeds are expected to reach HKD3.087 billion. Approximately 80% of the proceeds are intended for R&D-related expenditures, including: advancing clinical research in China and the US on innovative drug candidates in the R&D stage to accelerate pipeline progress, including but not limited to 705 (PD1/ HER2), 706 (PD1/PDL1), 008 (B7H3/IL15), 59 (MUC17/CD3/CD28), 626 (BDCA2) and 627 (TL1A); supporting indication expansions or clinical trials outside of China for commercialised drugs to further enhance product value and expand market reach; and building the global infrastructure and facilities. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
